Summary

The global biobanking market is witnessing remarkable growth, driven by the increasing demand for biological sample storage and the expansion of biomedical research worldwide. Biobanks, which collect, process, store, and distribute biological samples such as blood, tissues, and cells, are critical for medical research, drug development, and personalized medicine. With healthcare moving toward precision therapies, biobanking has become a cornerstone for advancing regenerative medicine, genomics, and life sciences.

According to recent market research, the biobanking market is projected to grow from USD 8.4 billion in 2026 to USD 15.5 billion by 2033, reflecting a CAGR of 9.10%. This growth is propelled by technological advancements in sample preservation, increasing research initiatives, and the rising prevalence of chronic diseases across the globe.

Market Insights

The growing importance of high-quality biological samples for research and clinical applications has fueled the expansion of the biobanking market. The surge in precision medicine programs has heightened the need for well-maintained sample repositories, enabling large-scale genomic studies and biomarker discovery. Biobanks provide pharmaceutical and research organizations with reliable access to biological specimens, expediting drug development and diagnostic innovation.

Currently, North America leads the global biobanking market, supported by advanced research infrastructure, high adoption of biobank services, and substantial government funding. Europe follows, with established biobanks that support clinical trials and translational research. Meanwhile, Asia Pacific is emerging as a high-growth region, driven by increased healthcare investments, growing research activities, and government initiatives promoting biomedical infrastructure.

Market Drivers

Several key factors are contributing to the growth of the biobanking market:

1. Rise of Personalized Medicine: The focus on individualized treatments has increased the demand for high-quality biological samples.

2. Technological Innovations: Automated sample storage systems, cryogenic preservation, and advanced bioinformatics solutions are improving operational efficiency.

3. Expanding R&D Activities: The growing number of clinical trials and biomedical research projects globally is creating a higher demand for organized biobanking services.

4. Increasing Chronic Disease Incidence: Conditions such as cancer, diabetes, and cardiovascular diseases are driving the need for disease-specific research samples.

5. Government Support and Funding: Initiatives and grants to establish and maintain biobanks, particularly in developed regions, are fueling market expansion.

Business Opportunities

The biobanking market offers significant opportunities for both established companies and new entrants. Collaborating with hospitals, research institutions, and pharmaceutical organizations can ensure a steady flow of biological samples. Expanding biobank services into emerging markets provides access to untapped research networks. Companies offering advanced storage technologies, automation, and digital sample management platforms are well-positioned to benefit from market growth. Emerging trends like AI integration and blockchain-based sample tracking are creating new opportunities for operational efficiency and data security.

Regional Analysis

• North America: Dominates the market due to well-established biobanks, high adoption of precision medicine, and extensive clinical research funding. The U.S. is the major contributor.

• Europe: Home to numerous biobanks across Germany, France, and the U.K., with support from EU-funded biomedical research initiatives.

• Asia Pacific: Expected to witness rapid growth, fueled by increasing research activity, healthcare investments, and government initiatives in countries like China, Japan, and India.

• Latin America: Emerging steadily with growing biobanking initiatives in Brazil and Mexico, supported by research funding.

• Middle East & Africa: Developing market, driven by healthcare infrastructure improvements and increasing focus on biomedical research.

Key Players

The biobanking market is highly competitive, with major players focusing on technological innovation, partnerships, and geographic expansion. Leading companies include:

• Thermo Fisher Scientific

• Qiagen N.V.

• Merck KGaA (MilliporeSigma)

• Sartorius AG

• Eppendorf AG

• Brooks Automation

• Chart Industries, Inc.

• Helmer Scientific

• BD (Becton, Dickinson and Company)

• Cryoport, Inc.

• Cytiva (part of Danaher)

• PerkinElmer, Inc.

• Greiner Bio One International GmbH

• PHC Corporation (formerly Panasonic Healthcare)

• BioStorage Technologies

These players are actively investing in product development, automation technologies, and strategic acquisitions to strengthen their presence in the growing market.

Market Segmentation

By Sample Storage:

• Blood

• Cells & Tissues

• Others

By Application:

• Regenerative Medicines

• Life Science

• Others

By Settings:

• Academic Medical Institutions

• Pharmaceutical & Biotechnological Companies

By Region:

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Biobanking Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Biobanking Market Outlook, 2020 - 2033
3.1. Global Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
3.1.1. Blood
3.1.2. Cells & Tissues
3.1.3. Others
3.2. Global Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
3.2.1. Regenerative Medicines
3.2.2. Life Science
3.2.3. Others
3.3. Global Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
3.3.1. Academic Medical Institutions
3.3.2. Pharmaceutical & Biotechnological Companies
3.4. Global Biobanking Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Biobanking Market Outlook, 2020 - 2033
4.1. North America Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
4.1.1. Blood
4.1.2. Cells & Tissues
4.1.3. Others
4.2. North America Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
4.2.1. Regenerative Medicines
4.2.2. Life Science
4.2.3. Others
4.3. North America Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
4.3.1. Academic Medical Institutions
4.3.2. Pharmaceutical & Biotechnological Companies
4.4. North America Biobanking Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.4.1. U.S. Biobanking Market Outlook, by Sample Storage, 2020-2033
4.4.2. U.S. Biobanking Market Outlook, by Application, 2020-2033
4.4.3. U.S. Biobanking Market Outlook, by Settings, 2020-2033
4.4.4. Canada Biobanking Market Outlook, by Sample Storage, 2020-2033
4.4.5. Canada Biobanking Market Outlook, by Application, 2020-2033
4.4.6. Canada Biobanking Market Outlook, by Settings, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Biobanking Market Outlook, 2020 - 2033
5.1. Europe Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
5.1.1. Blood
5.1.2. Cells & Tissues
5.1.3. Others
5.2. Europe Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
5.2.1. Regenerative Medicines
5.2.2. Life Science
5.2.3. Others
5.3. Europe Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
5.3.1. Academic Medical Institutions
5.3.2. Pharmaceutical & Biotechnological Companies
5.4. Europe Biobanking Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.4.1. Germany Biobanking Market Outlook, by Sample Storage, 2020-2033
5.4.2. Germany Biobanking Market Outlook, by Application, 2020-2033
5.4.3. Germany Biobanking Market Outlook, by Settings, 2020-2033
5.4.4. Italy Biobanking Market Outlook, by Sample Storage, 2020-2033
5.4.5. Italy Biobanking Market Outlook, by Application, 2020-2033
5.4.6. Italy Biobanking Market Outlook, by Settings, 2020-2033
5.4.7. France Biobanking Market Outlook, by Sample Storage, 2020-2033
5.4.8. France Biobanking Market Outlook, by Application, 2020-2033
5.4.9. France Biobanking Market Outlook, by Settings, 2020-2033
5.4.10. U.K. Biobanking Market Outlook, by Sample Storage, 2020-2033
5.4.11. U.K. Biobanking Market Outlook, by Application, 2020-2033
5.4.12. U.K. Biobanking Market Outlook, by Settings, 2020-2033
5.4.13. Spain Biobanking Market Outlook, by Sample Storage, 2020-2033
5.4.14. Spain Biobanking Market Outlook, by Application, 2020-2033
5.4.15. Spain Biobanking Market Outlook, by Settings, 2020-2033
5.4.16. Russia Biobanking Market Outlook, by Sample Storage, 2020-2033
5.4.17. Russia Biobanking Market Outlook, by Application, 2020-2033
5.4.18. Russia Biobanking Market Outlook, by Settings, 2020-2033
5.4.19. Rest of Europe Biobanking Market Outlook, by Sample Storage, 2020-2033
5.4.20. Rest of Europe Biobanking Market Outlook, by Application, 2020-2033
5.4.21. Rest of Europe Biobanking Market Outlook, by Settings, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Biobanking Market Outlook, 2020 - 2033
6.1. Asia Pacific Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
6.1.1. Blood
6.1.2. Cells & Tissues
6.1.3. Others
6.2. Asia Pacific Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
6.2.1. Regenerative Medicines
6.2.2. Life Science
6.2.3. Others
6.3. Asia Pacific Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
6.3.1. Academic Medical Institutions
6.3.2. Pharmaceutical & Biotechnological Companies
6.4. Asia Pacific Biobanking Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.4.1. China Biobanking Market Outlook, by Sample Storage, 2020-2033
6.4.2. China Biobanking Market Outlook, by Application, 2020-2033
6.4.3. China Biobanking Market Outlook, by Settings, 2020-2033
6.4.4. Japan Biobanking Market Outlook, by Sample Storage, 2020-2033
6.4.5. Japan Biobanking Market Outlook, by Application, 2020-2033
6.4.6. Japan Biobanking Market Outlook, by Settings, 2020-2033
6.4.7. South Korea Biobanking Market Outlook, by Sample Storage, 2020-2033
6.4.8. South Korea Biobanking Market Outlook, by Application, 2020-2033
6.4.9. South Korea Biobanking Market Outlook, by Settings, 2020-2033
6.4.10. India Biobanking Market Outlook, by Sample Storage, 2020-2033
6.4.11. India Biobanking Market Outlook, by Application, 2020-2033
6.4.12. India Biobanking Market Outlook, by Settings, 2020-2033
6.4.13. Southeast Asia Biobanking Market Outlook, by Sample Storage, 2020-2033
6.4.14. Southeast Asia Biobanking Market Outlook, by Application, 2020-2033
6.4.15. Southeast Asia Biobanking Market Outlook, by Settings, 2020-2033
6.4.16. Rest of SAO Biobanking Market Outlook, by Sample Storage, 2020-2033
6.4.17. Rest of SAO Biobanking Market Outlook, by Application, 2020-2033
6.4.18. Rest of SAO Biobanking Market Outlook, by Settings, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Biobanking Market Outlook, 2020 - 2033
7.1. Latin America Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
7.1.1. Blood
7.1.2. Cells & Tissues
7.1.3. Others
7.2. Latin America Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
7.2.1. Regenerative Medicines
7.2.2. Life Science
7.2.3. Others
7.3. Latin America Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
7.3.1. Academic Medical Institutions
7.3.2. Pharmaceutical & Biotechnological Companies
7.4. Latin America Biobanking Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.4.1. Brazil Biobanking Market Outlook, by Sample Storage, 2020-2033
7.4.2. Brazil Biobanking Market Outlook, by Application, 2020-2033
7.4.3. Brazil Biobanking Market Outlook, by Settings, 2020-2033
7.4.4. Mexico Biobanking Market Outlook, by Sample Storage, 2020-2033
7.4.5. Mexico Biobanking Market Outlook, by Application, 2020-2033
7.4.6. Mexico Biobanking Market Outlook, by Settings, 2020-2033
7.4.7. Argentina Biobanking Market Outlook, by Sample Storage, 2020-2033
7.4.8. Argentina Biobanking Market Outlook, by Application, 2020-2033
7.4.9. Argentina Biobanking Market Outlook, by Settings, 2020-2033
7.4.10. Rest of LATAM Biobanking Market Outlook, by Sample Storage, 2020-2033
7.4.11. Rest of LATAM Biobanking Market Outlook, by Application, 2020-2033
7.4.12. Rest of LATAM Biobanking Market Outlook, by Settings, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Biobanking Market Outlook, 2020 - 2033
8.1. Middle East & Africa Biobanking Market Outlook, by Sample Storage, Value (US$ Bn), 2020-2033
8.1.1. Blood
8.1.2. Cells & Tissues
8.1.3. Others
8.2. Middle East & Africa Biobanking Market Outlook, by Application, Value (US$ Bn), 2020-2033
8.2.1. Regenerative Medicines
8.2.2. Life Science
8.2.3. Others
8.3. Middle East & Africa Biobanking Market Outlook, by Settings, Value (US$ Bn), 2020-2033
8.3.1. Academic Medical Institutions
8.3.2. Pharmaceutical & Biotechnological Companies
8.4. Middle East & Africa Biobanking Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.4.1. GCC Biobanking Market Outlook, by Sample Storage, 2020-2033
8.4.2. GCC Biobanking Market Outlook, by Application, 2020-2033
8.4.3. GCC Biobanking Market Outlook, by Settings, 2020-2033
8.4.4. South Africa Biobanking Market Outlook, by Sample Storage, 2020-2033
8.4.5. South Africa Biobanking Market Outlook, by Application, 2020-2033
8.4.6. South Africa Biobanking Market Outlook, by Settings, 2020-2033
8.4.7. Egypt Biobanking Market Outlook, by Sample Storage, 2020-2033
8.4.8. Egypt Biobanking Market Outlook, by Application, 2020-2033
8.4.9. Egypt Biobanking Market Outlook, by Settings, 2020-2033
8.4.10. Nigeria Biobanking Market Outlook, by Sample Storage, 2020-2033
8.4.11. Nigeria Biobanking Market Outlook, by Application, 2020-2033
8.4.12. Nigeria Biobanking Market Outlook, by Settings, 2020-2033
8.4.13. Rest of Middle East Biobanking Market Outlook, by Sample Storage, 2020-2033
8.4.14. Rest of Middle East Biobanking Market Outlook, by Application, 2020-2033
8.4.15. Rest of Middle East Biobanking Market Outlook, by Settings, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Qiagen N.V.
9.4.3. Merck KGaA (MilliporeSigma)
9.4.4. Sartorius AG
9.4.5. Eppendorf AG
9.4.6. Brooks Automation
9.4.7. Chart Industries, Inc.
9.4.8. Helmer Scientific
9.4.9. BD (Becton, Dickinson and Company)
9.4.10. Cryoport, Inc.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations